Who owns Adaptimmune Therapeutics?
- Ticker: ADAP
- CUSIP Number: 00653a107
Tip: Access positions for across all investors
Analyze quarterly positions in Adaptimmune Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adaptimmune Therapeutics stock
Who bought or sold Adaptimmune Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Matrix Capital Management Company | 38M | $36M | -3% | Sep 2024 |
|
| EcoR1 Capital | 27M | $27M | 0% | Jun 2024 |
|
| NEA Management Company | 17M | $16M | 0% | Sep 2024 |
|
| Baillie Gifford & Co | 17M | $16M | 11% | Sep 2024 |
|
| Long Focus Capital Management | 13M | $13M | 24% | Sep 2024 |
|
| Partner Fund Management | 10M | $9.5M | -5% | Sep 2024 |
|
| MPM Asset Management | 5.6M | $5.4M | 0% | Jun 2024 |
|
| MPM Oncology Impact Management | 5.1M | $5.0M | 0% | Jun 2024 |
|
| Bank of America Corporation | 4.7M | $4.4M | 0% | Sep 2024 |
|
| Rock Springs Capital Management | 2.4M | $2.4M | 0% | Jun 2024 |
|
| Renaissance Technologies | 1.7M | $1.6M | -7% | Sep 2024 |
|
| Jpmorgan Chase & Co | 1.0M | $994k | 1% | Sep 2024 |
|
| Redmile Group | 716k | $680k | 0% | Sep 2024 |
|
| Marshall Wace | 523k | $497k | 261% | Sep 2024 |
|
| Morgan Stanley | 441k | $430k | 18% | Jun 2024 |
|
| Rathbones Brothers | 433k | $422k | 0% | Jun 2024 |
|
| State Street Corporation | 391k | $381k | 25% | Jun 2024 |
|
| DAFNA Capital Management | 341k | $324k | 0% | Sep 2024 |
|
| BlackRock | 284k | $270k | 100% | Sep 2024 |
|
| Key Client Fiduciary Advisors | 255k | $243k | -3% | Sep 2024 |
|
| Susquehanna International | 222k | $211k | -20% | Sep 2024 |
|
| BlackRock | 194k | $189k | -33% | Jun 2024 |
|
| Jane Street | 174k | $166k | 130% | Sep 2024 |
|
| Geode Capital Management | 140k | $133k | 19% | Sep 2024 |
|
| GSA Capital Partners | 100k | $95k | 100% | Sep 2024 |
|
| LPL Financial | 89k | $84k | -55% | Sep 2024 |
|
| Captrust Financial Advisors | 83k | $79k | 0% | Sep 2024 |
|
| Virtu Financial | 79k | $77k | 100% | Jun 2024 |
|
| Wells Fargo & Company | 67k | $64k | 5% | Sep 2024 |
|
| Northern Trust | 51k | $49k | -11% | Sep 2024 |
|
| Barclays | 50k | $48k | 0% | Sep 2024 |
|
| Group One Trading | 48k | $46k | 42% | Sep 2024 |
|
| Vontobel Holding | 43k | $41k | 231% | Sep 2024 |
|
| Oppenheimer & Co | 36k | $35k | -17% | Sep 2024 |
|
| Wealth Enhancement Advisory Services | 35k | $34k | 9% | Jun 2024 |
|
| Fullcircle Wealth | 35k | $26k | 100% | Sep 2024 |
|
| Invesco | 35k | $33k | 0% | Sep 2024 |
|
| Citadel Advisors | 34k | $32k | -85% | Sep 2024 |
|
| Two Sigma Advisers | 33k | $33k | -28% | Jun 2024 |
|
| Columbia Advisory Partners | 31k | $30k | 12% | Sep 2024 |
|
| CSS | 31k | $29k | 0% | Sep 2024 |
|
| DLK Investment Management | 31k | $29k | 0% | Sep 2024 |
|
| Massey, Quick & Co | 31k | $29k | 2% | Sep 2024 |
|
| Janney Montgomery Scott | 30k | $29k | 0% | Sep 2024 |
|
| Newman Dignan & Sheerar | 28k | $21k | 100% | Sep 2024 |
|
| Stifel Financial | 28k | $27k | 16% | Jun 2024 |
|
| IFG Advisory | 28k | $26k | 100% | Sep 2024 |
|
| Hsbc Holdings | 26k | $26k | 0% | Jun 2024 |
|
| Prosperity Wealth Management | 25k | $23k | -8% | Sep 2024 |
|
| Hunter Associates | 23k | $22k | 0% | Sep 2024 |
|
| Rhumbline Advisers | 19k | $18k | 15% | Sep 2024 |
|
| Ballentine Partners | 17k | $16k | 100% | Sep 2024 |
|
| Goldman Sachs Group | 16k | $16k | -85% | Jun 2024 |
|
| Advisor Group Holdings | 15k | $15k | -21% | Sep 2024 |
|
| Commonwealth Equity Services | 13k | $13k | -33% | Sep 2024 |
|
| Graham Capital Management | 13k | $12k | 100% | Sep 2024 |
|
| Quadrant Capital | 12k | $12k | 282% | Sep 2024 |
|
| Greenleaf Trust | 12k | $11k | 100% | Sep 2024 |
|
| X-Square Capital | 11k | $11k | 0% | Sep 2024 |
|
| Parallel Advisors | 7.2k | $6.8k | 2773% | Sep 2024 |
|
| Signature | 6.6k | $6.3k | 100% | Sep 2024 |
|
| Global Retirement Partners | 6.0k | $5.7k | 0% | Sep 2024 |
|
| Lindbrook Capital | 4.8k | $4.6k | 5% | Sep 2024 |
|
| Atlantic Trust | 3.0k | $2.9k | 0% | Sep 2024 |
|
| IFP Advisors | 3.0k | $2.9k | 100% | Jun 2024 |
|
| Simplex Trading | 1.1k | $0 | 100% | Sep 2024 |
|
| Sandy Spring Bank | 1.1k | $998.025000 | 0% | Sep 2024 |
|
| Plante Moran Financial Advisors | 925.00 | $879.027500 | 100% | Sep 2024 |
|
| Federation des caisses Desjardins du Quebec | 755.00 | $717.023500 | -4% | Sep 2024 |
|
| Carmichael Hill & Associates | 525.00 | $499.012500 | 0% | Sep 2024 |
|
| HighMark Wealth Management | 287.00 | $272.994400 | 0% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 213.00 | $202.009200 | 0% | Sep 2024 |
|
| Investors Research Corp | 100.00 | $95.000000 | 0% | Sep 2024 |
|
| Northwestern Mutual Wealth Management Company | 69.00 | $65.998500 | 100% | Sep 2024 |
|
| TD Waterhouse Canada | 14.00 | $13.000400 | 100% | Sep 2024 |
|
Who sold out of Adaptimmune Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Baker Bros. Advisors | Jun 2024 | 2.3M | $2.3M |
| Tang Capital Management | Jun 2024 | 1.7M | $1.7M |
| Millennium Management | Jun 2024 | 780k | $760k |
| Acuitas Investments | Jun 2024 | 541k | $528k |
| Marquette Asset Management | Jun 2024 | 99k | $96k |
| Main Street Financial Solutions | Mar 2024 | 31k | $49k |
| JTC Employer Solutions Trustee | Jun 2024 | 26k | $26k |
| Two Sigma Investments | Mar 2024 | 15k | $23k |
| XTX Topco | Jun 2024 | 12k | $12k |
| Baader Bank | Jun 2024 | 10k | $8.2k |
| Raymond James & Associates | Jun 2024 | 10k | $10k |
| Wetzel Investment Advisors | Jun 2024 | 6.0k | $9.5k |